Annotation 17Aug10: Difference between revisions

From GO Wiki
Jump to navigation Jump to search
m (Created page with 'Annotation * User documentation needs to be made, indicating how GO annotations can be filtered by users (e.g. alerting users to different annotation subsets IEAs/RCAs) [Wor…')
 
mNo edit summary
Line 1: Line 1:
Annotation
Annotation


    * User documentation needs to be made, indicating how GO annotations can be filtered by users (e.g. alerting users to different annotation subsets IEAs/RCAs) [Working group to be established; including Harold and Amelia]. Manager: Rama and Emily. AmiGO issue, QuickGO can do this.
* User documentation needs to be made, indicating how GO annotations can be filtered by users (e.g. alerting users to different annotation subsets IEAs/RCAs) [Working group to be established; including Harold and Amelia]. Manager: Rama and Emily.  
 
AmiGO issue, QuickGO can do this.
 
* ECO and GO evidence code documentation to be inline. Michelle and Evidence Code working group to investigate revamp of evidence codes. Manager: Emily and Rama


    * ECO and GO evidence code documentation to be inline. Michelle and Evidence Code working group to investigate revamp of evidence codes. Manager: Emily and Rama
ISMB meeting OBI ontology – merge the two? Need to talk to Michelle about this. Ask Judy to report back on ISMB PRO meeting.
ISMB meeting OBI ontology – merge the two? Need to talk to Michelle about this. Ask Judy to report back on ISMB PRO meeting.


    * Go forward with using ECO as the source for evidence codes and cross-reference to OBI and clarify distinction between experimental and predicted and to include user guidance regarding reviewed vs. Nonreviewed datasets. [Michelle and Evidence Code working group] Manager: Emily and Rama  
* Go forward with using ECO as the source for evidence codes and cross-reference to OBI and clarify distinction between experimental and predicted and to include user guidance regarding reviewed vs. Nonreviewed datasets. [Michelle and Evidence Code working group] Manager: Emily and Rama  
 
* Make a document with the agreed rules on limiting usage of GO term ‘protein binding; GO:0005515. [Binding working group] Manager: Emily. 
 
Done
 
* Look into using column 16 to capture targets in a more consistent manner as well as cases where you want to say a gp NOT binds a specific protein. [Column 16 working group]. Manager: Rama and Emily.
 
Rama to talk to Ruth and Judy (PRO) about this.
Binding group has been discussing this, have not yet made a working group for this.


    * Make a document with the agreed rules on limiting usage of GO term ‘protein binding; GO:0005515. [Binding working group] Manager: Emily. Done
* to investigate managing the automatic implementation of the protein binding rules centrally [Chris, Ben, Emily, Rama].  


    * Look into using column 16 to capture targets in a more consistent manner as well as cases where you want to say a gp NOT binds a specific protein. [Column 16 working group]. Manager: Rama and Emily. Binding group has been discussing this, have not yet made a working group for this.
Bulk of rules will be in filtering script, Mike to implement. Reciprocal annotations - inferences made by another script, up to individual groups to incorporate them (cross-species interaction may not be possible for some).  


    * to investigate managing the automatic implementation of the protein binding rules centrally [Chris, Ben, Emily, Rama].  
* Continue discussing the issue of 'drug' between now and the GO camp [Binding working group]. Manager: Emily


    * Continue discussing the issue of 'drug' between now and the GO camp [Binding working group]. Manager: Emily
* Work with IMEx to figure out how their annotations might be imported into GO [Emily, Chris].  


    * Work with IMEx to figure out how their annotations might be imported into GO [Emily, Chris].  
* improve the annotation guidelines based on feedback and analysis of the TB project [Rama].


    * improve the annotation guidelines based on feedback and analysis of the TB project [Rama].  
Rachael/Rama to summarise findings of review of M. tuberculosis annotations and send all correspondence to GO managers.


    * GOC website redesign: We should think of examples of what we want to do with the website for the grant renewal
* GOC website redesign: We should think of examples of what we want to do with the website for the grant renewal

Revision as of 11:04, 17 August 2010

Annotation

  • User documentation needs to be made, indicating how GO annotations can be filtered by users (e.g. alerting users to different annotation subsets IEAs/RCAs) [Working group to be established; including Harold and Amelia]. Manager: Rama and Emily.

AmiGO issue, QuickGO can do this.

  • ECO and GO evidence code documentation to be inline. Michelle and Evidence Code working group to investigate revamp of evidence codes. Manager: Emily and Rama

ISMB meeting OBI ontology – merge the two? Need to talk to Michelle about this. Ask Judy to report back on ISMB PRO meeting.

  • Go forward with using ECO as the source for evidence codes and cross-reference to OBI and clarify distinction between experimental and predicted and to include user guidance regarding reviewed vs. Nonreviewed datasets. [Michelle and Evidence Code working group] Manager: Emily and Rama
  • Make a document with the agreed rules on limiting usage of GO term ‘protein binding; GO:0005515. [Binding working group] Manager: Emily.

Done

  • Look into using column 16 to capture targets in a more consistent manner as well as cases where you want to say a gp NOT binds a specific protein. [Column 16 working group]. Manager: Rama and Emily.

Rama to talk to Ruth and Judy (PRO) about this. Binding group has been discussing this, have not yet made a working group for this.

  • to investigate managing the automatic implementation of the protein binding rules centrally [Chris, Ben, Emily, Rama].

Bulk of rules will be in filtering script, Mike to implement. Reciprocal annotations - inferences made by another script, up to individual groups to incorporate them (cross-species interaction may not be possible for some).

  • Continue discussing the issue of 'drug' between now and the GO camp [Binding working group]. Manager: Emily
  • Work with IMEx to figure out how their annotations might be imported into GO [Emily, Chris].
  • improve the annotation guidelines based on feedback and analysis of the TB project [Rama].

Rachael/Rama to summarise findings of review of M. tuberculosis annotations and send all correspondence to GO managers.

  • GOC website redesign: We should think of examples of what we want to do with the website for the grant renewal